Chardan: Sell Axovant Sciences, RVT-101 Market Pricing Is 'Highly Irrational'
June 18, 2015 at 09:37 AM EDT
In a report published Thursday, Chardan Capital analyst Gbola Amusa initiated coverage of Axovant Sciences Ltd (NYSE: AXON) with a Sell ...